Olaf Hardt

Company: Miltenyi Biotec
Job title: Senior Manager, Research and Development
Seminars:
Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy 9:30 am
Miltenyi Biotec presents the MACSima Ultra-high content imaging platform Learn how MICS technology enables you to visualize hundreds of markers from fixed tissue to lift your sample analysis to the next level See a comprehensive workflow for the identification of new target candidatesRead more
day: Day Two